Antimicrobial Peptides and Systemic Inflammation: A Network Analysis

Immunity, Inflammation and Disease · Published 2026-04-01 · DOI 10.1002/iid3.70446

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1002/iid3.70446

Abstract

ABSTRACT Introduction Antimicrobial peptides (AMPs) are essential components of the innate immune system, exhibiting diverse mechanisms of action. Objective This study investigates the roles of cathelicidin (LL‐37), alpha‐defensins, and the S100 proteins S100A8 and S100A9 in systemic inflammation associated with sepsis, severe COVID‐19, and acute pancreatitis using whole‐blood bulk RNA‐sequencing data. Results Gene co‐expression network analysis revealed that during septic shock and severe COVID‐19, cathelicidin and alpha‐defensins act synergistically in innate immune responses, while S100A8 and S100A9 function through distinct pathways related to mitochondrial metabolism and ubiquitin ligase binding. In contrast, the acute pancreatitis network displayed a different pattern, with CAMP co‐expressed alongside S100A8 and S100A9, whereas alpha‐defensins were downregulated and associated with inhibited mucosal immune responses. Conclusion These findings suggest that antimicrobial peptides contribute variably to systemic inflammation depending on the underlying insult, underscoring their complex, context‐dependent roles in critical illness.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2026

Related articles